Abstract

Currents15 March 1998U.S. Dialysis Survival StrategyCarol Cruzan MortonCarol Cruzan MortonSearch for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-128-6-199803150-00039 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail Renal dialysis in the United States has been called a scandal and a success. To a certain extent, both views are correct.“Nearly one fourth of the patients on dialysis in the U.S. die each year,” said Nathan Levine, MD, cochief of the division of nephrology and hypertension at Beth Israel Medical Center in New York City. “That figure is needlessly high and avoidable.”In contrast, Eli Friedman, MD, Department of Medicine, State University of New York Health Science Center at Brooklyn, characterized treatment of end-stage renal disease (ESRD) as an American success story. “Uremia therapy stands as the only ... Author, Article, and Disclosure InformationAuthors: Carol Cruzan MortonAffiliations: PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited byPrevalence and Risk Factors of Myocardial Remodeling in Hemodialysis Patients 15 March 1998Volume 128, Issue 6Page: 514-516KeywordsDeath ratesKidneysMedical dialysisMortalityNephrologyNutritionRenal diseasesRenal failureRenal systemTreatment guidelines ePublished: 15 August 2000 Issue Published: 15 March 1998 Copyright & PermissionsCopyright © 1998 by American College of Physicians. All Rights Reserved.PDF downloadLoading ...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call